Release Date: 30/10/17 16:20 Summary: Quarterly Activities Report and Quarterly Cashflow Report Price Sensitive: Yes Download Document 1.94MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%